James Neville Fairbairn

This profile gathers the share dealings of James Neville Fairbairn in XORTX Therapeutics Inc. (formerly: APAC Resources Inc.). In total, 10 filings cover trades dated from 5 November 2018 to 28 February 2021.

Every open-market trade on record is a purchase: 5 purchases worth €23k, and no sale. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Other entries cover 1 option exercise.

The median purchase comes to €5,058. The 4 purchases reviewed show no overlap with other insiders buying the same stock within a month.

Most recently, on 3 March 2021, the filings show an option exercise worth €24k in XORTX Therapeutics Inc. (formerly: APAC Resources Inc.). The last purchase on record was published on 14 October 2020, which is 2,201 days ago. Filings reach the SEDI feed a median of 1 day after the trade. That lag is the time during which only the insider knows about the trade. These figures are compiled from regulatory filings published by SEDI. They describe what insiders did and are not a recommendation.